Microfluidics contrasted to thrombelastography:perplexities in defining hypercoaguladility
| No. | 39 |
|---|---|
| Citation | J Surg Res 231,p54-61(2018) |
| Institute | University of Colorado School of Medicine |
| 1st Author | P Lawson |
| AR | ○ |
| PL | ○ |
| HD | |
| Paper types | Clinical investigations |
| Main purpose | Device comparison |
| Disease | Hypercoagulability |
| Antiplatelet drug | |
| Anticoagulant drug | |
| Other drug | |
| Clinical specimens | Patients with pancreatic cancer, Patients with inflammatory bowel disease |
| Animal | |
| Keyword |